These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 36327286

  • 1. Dopamine versus norepinephrine as the first-line vasopressor in the treatment of cardiogenic shock.
    Na SJ, Yang JH, Ko RE, Chung CR, Cho YH, Choi KH, Kim D, Park TK, Lee JM, Song YB, Choi JO, Hahn JY, Choi SH, Gwon HC.
    PLoS One; 2022; 17(11):e0277087. PubMed ID: 36327286
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of dopamine versus norepinephrine in the management of septic shock.
    Patel GP, Grahe JS, Sperry M, Singla S, Elpern E, Lateef O, Balk RA.
    Shock; 2010 Apr; 33(4):375-80. PubMed ID: 19851126
    [Abstract] [Full Text] [Related]

  • 3. Norepinephrine or dopamine for septic shock: systematic review of randomized clinical trials.
    Vasu TS, Cavallazzi R, Hirani A, Kaplan G, Leiby B, Marik PE.
    J Intensive Care Med; 2012 Apr; 27(3):172-8. PubMed ID: 21436167
    [Abstract] [Full Text] [Related]

  • 4. Dopamine versus norepinephrine in the treatment of shock.
    Nathan Coxford R, Lang E, Dowling S.
    CJEM; 2011 Nov; 13(6):395-7. PubMed ID: 22436478
    [Abstract] [Full Text] [Related]

  • 5. THE EFFICACY AND SAFETY OF VASOPRESSORS FOR SEPTIC SHOCK PATIENTS: A SYSTEMIC REVIEW AND NETWORK META-ANALYSIS.
    Jia L, Wang P, Li C, Xie J.
    Shock; 2023 Dec 01; 60(6):746-752. PubMed ID: 37548686
    [Abstract] [Full Text] [Related]

  • 6. Comparison of dopamine and norepinephrine in the treatment of shock.
    De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, Brasseur A, Defrance P, Gottignies P, Vincent JL, SOAP II Investigators.
    N Engl J Med; 2010 Mar 04; 362(9):779-89. PubMed ID: 20200382
    [Abstract] [Full Text] [Related]

  • 7. Comparison of Clinical Outcomes with Initial Norepinephrine or Epinephrine for Hemodynamic Support After Return of Spontaneous Circulation.
    Weiss A, Dang C, Mabrey D, Stanton M, Feih J, Rein L, Feldman R.
    Shock; 2021 Dec 01; 56(6):988-993. PubMed ID: 34172611
    [Abstract] [Full Text] [Related]

  • 8. Effect of norepinephrine on the outcome of septic shock.
    Martin C, Viviand X, Leone M, Thirion X.
    Crit Care Med; 2000 Aug 01; 28(8):2758-65. PubMed ID: 10966247
    [Abstract] [Full Text] [Related]

  • 9. Norepinephrine versus epinephrine for hemodynamic support in post-cardiac arrest shock: A systematic review.
    Lawson CK, Faine BA, Rech MA, Childs CA, Brown CS, Slocum GW, Acquisto NM, Ray L, EMPHARM-NET Study Group.
    Am J Emerg Med; 2024 Mar 01; 77():158-163. PubMed ID: 38150986
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study).
    Póvoa PR, Carneiro AH, Ribeiro OS, Pereira AC, Portuguese Community-Acquired Sepsis Study Group.
    Crit Care Med; 2009 Feb 01; 37(2):410-6. PubMed ID: 19114885
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of dopamine and norepinephrine in shock.
    De Santis V, Nencini C, Tritapepe L.
    N Engl J Med; 2010 Jun 17; 362(24):2329; author reply 2330-1. PubMed ID: 20560160
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis.
    Avni T, Lador A, Lev S, Leibovici L, Paul M, Grossman A.
    PLoS One; 2015 Jun 17; 10(8):e0129305. PubMed ID: 26237037
    [Abstract] [Full Text] [Related]

  • 20. Days alive and free as an alternative to a mortality outcome in pivotal vasopressor and septic shock trials.
    Russell JA, Lee T, Singer J, De Backer D, Annane D.
    J Crit Care; 2018 Oct 17; 47():333-337. PubMed ID: 29958734
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.